Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
Temporomandibular Joint Disorders, Extracorporeal Shockwave Therapy
About this trial
This is an interventional treatment trial for Temporomandibular Joint Disorders focused on measuring Temporomandibular Joint Disorders, Extracorporeal Shockwave Therapy, Temporomandibular Joint Dysfunction Syndrome, High-Energy Shock Waves, Pain Management
Eligibility Criteria
Inclusion Criteria: Pain in the temporomandibular region; Myofascial pain diagnosed with or without limitation of mouth opening based on the Diagnostic Criteria for TMD (DC/TMD); Myofascial pain associated or not with joint abnormalities; Presence of moderate to severe pain: Visual Analogue Scale (VAS) >4; Duration of TMD pain (temporomandibular musculoskeletal) ≥3 months; Written granting of the informed consent form to participate in the study Exclusion Criteria: Abnormality in blood clotting (coagulopathy) or using some type of anticoagulant; Primary malignant disease (tumors) in the treatment area; Acute infection of soft tissue or bone; Systemic infections; Epilepsy; Infiltration of corticosteroids at the application site in the last 6 weeks; Patient at high risk of some type of anesthesia or analgesia when it eventually has to be used; Polyarthritis; Polytrauma Local joint infections; Previous temporomandibular surgical treatments that compromise mastication; Treatment by physiotherapy, acupuncture before 3 months of performing the procedures Depression or other mental disorders; Clinical diagnosis of associated fibromyalgia; Associated systemic inflammatory rheumatic diseases; Widespread pain or pain elsewhere that predominates and overlaps with TMD muscle pain; Inability to understand the treatment protocol.
Sites / Locations
- University of São Paulo General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Treatment group
Placebo
Treatment group will undergo treatment with focal shock wave therapy for 5 weeks, with weekly sessions and guidance by a trained physiotherapist on habits, stretching and exercises for adequate strengthening and ergonomic guidelines to promote a better quality of life
Patients in the placebo group will undergo treatment with placebo focal shockwave therapy (using a dummy applicator) for 5 weeks and guidance by a trained physiotherapist on habits, stretching and exercises for adequate strengthening and ergonomic guidelines to promote a better quality of life